4
Changes in Ownership
PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001493152-24-008274
Options or other derivatives
- CFO returned 0 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Raines Heather CFO | 2024-02-28 | Returned to the company · 8% Unsecured Convertible Promissory Note due 2022 | −0 | $50,000.00 | $0 | D: show line 1 in the form |
Loading xslF345X05/ownership.xml…